Atlas Trials

Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

Clinical trial NCT04675320 · UNKNOWN

Trial details

NCT number
NCT04675320
Sponsor
Centre Georges Francois Leclerc
Status
UNKNOWN
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2020-07-07
Primary completion
2022-11-10
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.